This petition is taking off on Change.org, and we think you might be interested in adding your name. Sign now to help: | ||
fast track human trials and save lives from cancer | ||
| ||
| ||
ErSO is a new class of drug being developed that has the potential to eradicate estrogen positive breast cancer. This drug could treat more than 70% of all breast cancers! ErSO was developed by scientists at the University of Illinois and is now being developed and tested by Systems Oncology. ErSO is awaiting FDA clearance to start human trials. Those of us living with cancer, especially stage IV metastatic breast cancer (MBC), need trials fast tracked. Your action could very well save lives; 118 of us die from MBC every day in the US alone. First complete this short form and in the "question or comment" section, urge the FDA to "expedite ErSO to human trials; we need new treatments for breast cancer." Then sign the petition. We have love and science on our side. Take that, cancer.... | ||
| ||
In this blog, we'll look at how men and women at serving Jesus Christ both at home and abroad. We'll focus on how God is using their work to transform the lives of people all over the world.
Monday, June 27, 2022
Change.org Petition: fast track human trials and save lives from cancer
Subscribe to:
Post Comments (Atom)
Today in the Mission Yearbook - For the past decade, Presbyterian Hunger Program has partnered with a Gaza organization working on food security
Witness, Share and Evangelize: Today in the Mission Yearbook - For the past decad... : PHP works with Improvement and Development for Commun...
-
Capital punishment has been a widely debated topic in the United States for many years. In 1972, following the Furman v. Georgia Supreme Co...
-
Genocide, Worker Rights, and White Christian Nationalism NCC Newsletter July 2, 2021 Click here to donate Recent Interview with Jim Winkl...
-
“I will say to the Lord, “You are my refuge, my fortress, and my God in whom I trust!” Psalm 91:2 As we see the news and hear the stories of...
No comments:
Post a Comment